# Endoquest Robotics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/endoquest-robotics

- Industry: Medical Devices & Equipment
- Headquarters: Houston, US
- Website: www.endoquestrobotics.com/
- Total disclosed funding: $73M
- Latest round: Series D (May 19, 2025)
- Investors on record: 5

## About

Founded in 2017 and based in Texas, US, Endoquest Robotics, Inc. designs and manufactures surgical equipment like the endoluminal surgical system for treating gastrointestinal diseases. As of 2023, the company is headed by its CEO Kurt Azarbarzin. In May 2025, Endoquest Robotics, Inc. raised USD 30.7 million in series D funding co-led by new investor Crescent Enterprises Venture Capital and an individual investor, with participation from new investor University of Texas System and returning investor Puma Venture Capital. The round was part of a larger USD 39.6 million in series D funding. The company offers an endoluminal and single–incision robotic surgical system for conducting upper and lower gastrointestinal surgery. The firm system combines apparatus that permits the surgeon to do a traditional two-handed surgical procedure with the flexibility of endoscopy, which can negotiate the curve of the patient's anatomy. With the use of the firm system, minimally invasive surgery can be carried out within the gastrointestinal tract by therapeutic endoscopists and surgeons. The company plans to use the May 2025 funding to advance its surgical platform, support the PARADIGM clinical trial, accelerate FDA clearance, and progress early feasibility studies and visualization technologies.

## Funding rounds

- Series D, May 19, 2025, $31M — University of Texas System, Crescent Enterprises Venture Capital, Puma Venture Capital
- Series C, Dec 4, 2023, $42M — McNair Interests, CE Venture Capital, Puma Venture Capital

## Investors

- McNair Interests — Series C
- CE Venture Capital (https://capitalatlas.ai/funds/ce-venture-capital) — Series C
- Puma Venture Capital (https://capitalatlas.ai/funds/puma-venture-capital) — Series C, Series D
- University of Texas System — Series D
- Crescent Enterprises Venture Capital (https://capitalatlas.ai/funds/crescent-enterprises-venture-capital) — Series D